↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer
Overview of attention for article published in Investigational New Drugs, January 2005
Altmetric Badge
Mentioned by
patent
1
patent
Citations
dimensions_citation
17
Dimensions
Readers on
mendeley
6
Mendeley
Summary
Patents
Dimensions citations
So far, Altmetric has seen
1
patent that references this research output.
Combination therapy comprising cloretazine
Grant US-7605137-B2
United States of America
20 Oct 2009